Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis

Journal of the Pakistan Medical Association

Volumn 59, Issue 5, 2009, Pages 290-292

  Aurangzeb, Sidra ^a   Tariq, Muhammad ^a   Irshad, Muhammad ^a   Badshah, Mazhar ^a   Khan, Rao Suhail Y ^a  

^a PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; NEOSTIGMINE; AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE SEVERITY; FATIGUE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE STIMULATION; OUTPATIENT; TREATMENT OUTCOME; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PAKISTAN; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PAKISTAN; PROSPECTIVE STUDIES; RECEPTORS, CHOLINERGIC; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; YOUNG ADULT;

EID: 65949124455     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kothari MJ. Myasthenia Gravis. J Am Osteopath Assoc 2004;104:377-384
2. Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad Med J 2004; 80:690-700. (Pubitemid 39627099)
3. Poulas K , Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, et al. Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001; 71: 352-356
4. Vincent A, Clover L, Buckley C, Evans JG, Rothwell PM; UK Myasthenia Gravis Survey. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003; 74:1105-1108 (Pubitemid 36936389)
5. Robertson NP, Deans J, Compston DAS. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65:492-496
6. Osserman KE, Genkins G. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. M Sinai J Med 1971; 38:497-537.
7. Griesmann GE, Kryzer TJ, Lennon VA. Autoantibody profiles of myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Laboratory Immunology. 6th ed. ASM Press, 2002, pp 1005-1012 (Online) Cited 28 July 2008. Available from URL: http://www.labcorp. com/datasets/labcorp/html/chapter/mono/sr000100.htm
8. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology1976; 26:1054-1059
9. Appel SH, Anwyl R, McAdams MW, Elias S. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc Natl Acad Sci USA 1977; 74:2130-2134 (Pubitemid 8123625)
10. Drachman DB. Myasthenia Gravis. N Engl J Med 1994; 330:1797-1810
11. Drachman DB, Adams RN, Josifek LF, Self SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-775 (Pubitemid 12061550)
12. Drachman D. Myasthenia gravis: A model disorder of acetylcholine receptors. Res Nerv Ment Dis 1987; 65:65-82.
13. Engel A, Sahashi K, Fumagalli G. Effect of acetylcholine receptor structure and function: The immunopathology of acquired myasthenia gravis. Ann NY Acad Sci 1981; 377:158-174
14. Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 1978; 147:973-983
15. Oosterhuis HJ, Limburg PC, Hummel-Tappel E. The TH anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J Neurol Sci 1983; 58:371-385
16. Hoch W , McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368 (Pubitemid 32224355)
17. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003; 2:99-106. (Pubitemid 37443330)
18. Romi F, Skeie GO, Gilhus NE. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 2005; 62:442-446 (Pubitemid 40349480)
19. Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Terayama Y, Suzuki N, et al. Classification of Myasthenia Gravis Based on Autoantibody Status. Arch Neurol 2007; 64: 1121-1124
20. Newsome-Davis J, Harcourt G, Sommer N, Beeson D, Willcox N, Rothbard JB. T-cell reactivity in myasthenia gravis. J Autoimmun 1989; 2 suppl :101-108